Search

Your search keyword '"Asaoku, Hideki"' showing total 385 results

Search Constraints

Start Over You searched for: Author "Asaoku, Hideki" Remove constraint Author: "Asaoku, Hideki"
385 results on '"Asaoku, Hideki"'

Search Results

4. Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)—a trial by the Asian Myeloma Network

5. Supplementary Data from Genomic Screening for Genes Silenced by DNA Methylation Revealed an Association between RASD1 Inactivation and Dexamethasone Resistance in Multiple Myeloma

6. Anti‐CD38 antibody isatuximab monotherapy for Japanese individuals with relapsed/refractory multiple myeloma: An update of the phase 1/2 ISLANDs study

7. Anti‐CD38 antibody isatuximab monotherapy for Japanese individuals with relapsed/refractory multiple myeloma: An update of the phase 1/2 ISLANDs study.

12. Phase II study of ABVd therapy for newly diagnosed clinical stage II–IV Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG 9305)

14. Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan

21. Outcomes of methotrexate‐associated lymphoproliferative disorders in rheumatoid arthritis patients treated with disease‐modifying anti‐rheumatic drugs

23. Isatuximab monotherapy in relapsed/refractory multiple myeloma: A Japanese, multicenter, phase 1/2, safety and efficacy study

24. Central nervous system involvement in intravascular large B-cell lymphoma: A retrospective analysis of 109 patients

25. Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman disease

31. Clinicopathological significance of CD79a expression in classic Hodgkin lymphoma

33. Enhanced production of osteopontin in multiple myeloma: clinical and pathogenic implications

41. Significance of Soluble Interleukin-2 Receptor to Predict Prognosis and Support Decision-Making on Watchful Waiting for Stage II-IV Follicular Lymphoma Patients in the Rituximab Era

42. Allogeneic Hematopoietic Stem Cell Transplantation Using Fludarabine/Melphalan and Low-Dose Total Body Irradiation: A Single Center Analysis

43. Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myeloma

45. Watch-and-wait policyversusrituximab-combined chemotherapy in Japanese patients with intestinal follicular lymphoma

49. A New Prognostic Scoring System for Multiple Myeloma in the Era of Novel Agents and Autologous Stem Cell Transplantation: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma

50. Watch‐and‐wait policy versus rituximab‐combined chemotherapy in Japanese patients with intestinal follicular lymphoma.

Catalog

Books, media, physical & digital resources